Alternative Medical Marijuana Delivery Systems Gaining Popularity

Alternative Medical Marijuana Delivery Systems Gaining Popularity

Cannabis BioTech exploring options for patients not wanting to 'smoke pot'

FT. LAUDERDALE, Fla.--(BUSINESS WIRE)-- Puget Technologies (OTCBB: PUGE) announced its new subsidiary, Cannabis BioTech, is exploring alternative delivery systems for medical marijuana. This is in response to the growing health-conscious segment of the population that recognizes the benefits of medical marijuana but do not want the harmful effects or stigma of smoking it.

President and CEO of Puget Technologies Ron Leyland said, "Cannabis continues to gain acceptance as an alternative to opiates, anti-depressants and other toxic drugs, and the ways in which it is being consumed are drastically changing."

Cannabis BioTech is investigating alternatives such as topical applications and infusing active ingredients into foods and beverages, which will open up the benefits to a significantly larger segment of the population. The company is also exploring sophisticated transmucosal delivery systems (administered through the mucous membranes).

According to a recent Pew Research report, for the first time in more than 40 years a majority of Americans favor legalization of marijuana use. The manner in which it is consumed is producing a fast-growing industry in alternative delivery methods. The Wall Street Journal reported the $1.7 billion U.S. medical marijuana market will quadruple in size during the next five years.

Currently 20 states and the District of Columbia have enacted laws to legalize the use of medical marijuana.

CNN Chief Medical Correspondent Dr. Sanjay Gupta recently made global headlines when he changed his mind about cannabis, saying science backs the use of medical marijuana. According to an article based on Gupta's recent documentary, "WEED," there are several medical conditions for which patients can use cannabis - cancer, glaucoma, HIV/AIDS, muscle spasms, seizures, severe pain, severe nausea, dramatic weight loss and muscle atrophy.

More information about Cannabis BioTech can be found at

About Puget Technologies (PUGE)

Puget Technologies is a publicly traded company on the OTCBB Market stock exchange under the ticker symbol PUGE. Headquartered in Ft. Lauderdale, Florida, Puget Technologies acquires, develops and sells leading edge consumer oriented products ready for rapid commercialization. Puget plans to become a recognized market leader in its product categories. Much of its resources are dedicated to research and development in order to provide consumers with quality options while meeting the expectations of its investors.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release only speaks as of the date of its distribution.

Puget Technologies
Ron Leyland 954-332-2471

KEYWORDS:   United States  North America  Florida


The article Alternative Medical Marijuana Delivery Systems Gaining Popularity originally appeared on

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story